Home › Bile Duct Cancer (Cholangiocarcinoma) › Minnesota › Rochester
Bile Duct Cancer (Cholangiocarcinoma) clinical trials in Rochester, MN
7 studies for Bile Duct Cancer (Cholangiocarcinoma) are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
RecruitingPhase 1/2
- Mayo Clinic in Rochester, Rochester
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
- Mayo Clinic - Rochester, Rochester
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
RecruitingObservational study
- Mayo Clinic, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Recruiting
- Mayo Clinic, Rochester
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic in Rochester, Rochester
Biobank for Cholestatic Liver Diseases.
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic, Rochester
The Dragon PLC Trial (DRAGON-PLC)
Recruiting
- Mayo Clinic, Rochester
Bile Duct Cancer (Cholangiocarcinoma) trials in other cities
- Houston, TX13 studies
- New York City, NY11 studies
- Boston, MA8 studies
- Arlington, VA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Columbus, OH6 studies
- Cleveland, OH6 studies
- Queens, NY5 studies
- Edison, NJ5 studies
- Grand Rapids, MI5 studies
- Nashville, TN5 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Pancreatic Cancer22 studies
- Endometrial Cancer20 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.